Jinling Pharmaceutical Company Limited (SHE:000919)

China flag China · Delayed Price · Currency is CNY
7.42
+0.04 (0.54%)
At close: Mar 10, 2026
10.75%
Market Cap 4.61B
Revenue (ttm) 3.13B
Net Income (ttm) 32.11M
Shares Out 621.92M
EPS (ttm) 0.05
PE Ratio 143.13
Forward PE n/a
Dividend 0.10 (1.36%)
Ex-Dividend Date Jul 8, 2025
Volume 5,903,900
Average Volume 10,393,019
Open 7.42
Previous Close 7.38
Day's Range 7.36 - 7.45
52-Week Range 5.90 - 8.24
Beta 0.44
RSI 45.89
Earnings Date Mar 31, 2026

About SHE:000919

Jinling Pharmaceutical Company Limited manufactures and sells pharmaceutical products in China and internationally. The company offers Mailuoning injection/oral solutions for the treatment of thromboangiitis obliterans, arteriosclerosis obliterans, cerebral thrombosis and sequelae, multiple arteriosclerosis, phlebitis, acute arterial embolism of the limbs, diabetic gangrene, venous thrombosis, and thrombophlebitis, etc., as well as cardiovascular and cerebrovascular diseases; Sulifei ferrous aluminate tablets for the prevention and treatment of... [Read more]

Sector Healthcare
Founded 1998
Employees 5,789
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 000919
Full Company Profile

Financial Performance

In 2024, SHE:000919's revenue was 3.28 billion, an increase of 2.74% compared to the previous year's 3.19 billion. Earnings were 40.41 million, a decrease of -61.95%.

Financial Statements

News

There is no news available yet.